{"id":"https://openalex.org/W4362477282","doi":"https://doi.org/10.1158/1535-7163.22498735","title":"Supplementary Figure 5 from Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity","display_name":"Supplementary Figure 5 from Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362477282","doi":"https://doi.org/10.1158/1535-7163.22498735"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22498735","doi":"https://doi.org/10.1158/1535-7163.22498735","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22498735","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.22498735","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100780036","display_name":"Yu Cao","orcid":"https://orcid.org/0000-0002-9682-0980","observed_orcids":["https://orcid.org/0000-0002-9682-0980"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu Cao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038349275","display_name":"James D. Marks","orcid":"https://orcid.org/0000-0003-0562-3517","observed_orcids":["https://orcid.org/0000-0003-0562-3517"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James D. Marks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101856574","display_name":"Qian Huang","orcid":"https://orcid.org/0000-0002-3778-2419","observed_orcids":["https://orcid.org/0000-0002-3778-2419"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qian Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061278758","display_name":"Stephen I. Rudnick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen I. Rudnick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068012778","display_name":"Chiyi Xiong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chiyi Xiong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073876235","display_name":"Walter N. Hittelman","orcid":"https://orcid.org/0000-0002-0048-6640","observed_orcids":["https://orcid.org/0000-0002-0048-6640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Walter N. Hittelman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100580537","display_name":"Xiaoxia Wen","orcid":"https://orcid.org/0000-0002-7749-0744","observed_orcids":["https://orcid.org/0000-0002-7749-0744"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoxia Wen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083046767","display_name":"John W. Marks","orcid":"https://orcid.org/0009-0000-0035-2872","observed_orcids":["https://orcid.org/0009-0000-0035-2872"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John W. Marks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102752340","display_name":"Lawrence H. Cheung","orcid":"https://orcid.org/0000-0002-6715-6574","observed_orcids":["https://orcid.org/0000-0002-6715-6574"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence H. Cheung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003675387","display_name":"Kim Boland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kim Boland","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100373897","display_name":"Chun Li","orcid":"https://orcid.org/0000-0002-2376-4703","observed_orcids":["https://orcid.org/0000-0002-2376-4703"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chun Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050269562","display_name":"Gregory Paul Adams","orcid":"https://orcid.org/0000-0003-4207-2881","observed_orcids":["https://orcid.org/0000-0003-4207-2881"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory P. Adams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048281793","display_name":"Michael G. Rosenblum","orcid":"https://orcid.org/0000-0002-3044-6121","observed_orcids":["https://orcid.org/0000-0002-3044-6121"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael G. Rosenblum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.03739999979734421,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/single-chain-antibody","display_name":"single-chain antibody","score":0.8849999904632568},{"id":"https://openalex.org/keywords/immunotoxins","display_name":"immunotoxins","score":0.8479999899864197},{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.9200000166893005},{"id":"https://openalex.org/keywords/antibody-affinity","display_name":"antibody affinity","score":0.6499999761581421},{"id":"https://openalex.org/keywords/off-target-toxicity","display_name":"off-target toxicity","score":0.7590000033378601},{"id":"https://openalex.org/keywords/bt474-xenograft","display_name":"BT474 xenograft","score":0.8619999885559082},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.909210741519928},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5876124501228333},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.46853557229042053},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4577462077140808},{"id":"https://openalex.org/C36394416","wikidata":"https://www.wikidata.org/wiki/Q949267","display_name":"Immunoglobulin light chain","level":3,"score":0.4114704132080078},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.35793063044548035},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3510505259037018},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3307208716869354},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3272780776023865},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24817565083503723},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1628451943397522}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22498735","doi":"https://doi.org/10.1158/1535-7163.22498735","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22498735","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22498735.v1","doi":"https://doi.org/10.1158/1535-7163.22498735.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22498735.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_Single-Chain_Antibody-Based_Immunotoxins_Targeting_Her2_neu_Design_Optimization_and_Impact_of_Affinity_on_Antitumor_Efficacy_and_Off-Target_Toxicity/22498735/1/files/39957118.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22498735","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_Single-Chain_Antibody-Based_Immunotoxins_Targeting_Her2_neu_Design_Optimization_and_Impact_of_Affinity_on_Antitumor_Efficacy_and_Off-Target_Toxicity/22498735","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22498735","doi":"https://doi.org/10.1158/1535-7163.22498735","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22498735","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362477282.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362478068","https://openalex.org/W2117884978","https://openalex.org/W2324623325","https://openalex.org/W1980023938","https://openalex.org/W2070942888","https://openalex.org/W4361825112","https://openalex.org/W2117203118","https://openalex.org/W2092630337","https://openalex.org/W2353112260","https://openalex.org/W2007336991"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"1877KB,":[3],"Statistical":[4],"comparisons":[5],"of":[6,15],"Tissue-to-Muscle":[7],"Ratio":[8],"(tumor":[9],"or":[10],"liver":[11],"to":[12,26],"muscle":[13],"ratio)":[14],"IRDye800-MH3-B1/rGel":[16],"and":[17,22],"IRDye800-B1D3/rGel":[18],"after":[19],"24h":[20],"(A)":[21],"72h":[23],"(B)":[24],"injection":[25],"BT474":[27],"M1":[28],"xenograft":[29],"tumors.":[30]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}